Companies: 10,795·Total market cap: $144.5T
ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

ANIPNASDAQHealthcare● Active
$81.11
+$1.91(+2.41%)
Market Cap$1.8B
P/E Ratio
52W High$99.5
52W Low$59.61
Overview

ANI Pharmaceuticals, Inc.(ANIP)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ANIP · 截至 Jun 8, 2026

关键指标

EPS (TTM)$4.11anip eps ttm · anip earnings per shareEarnings history
PE Ratio (TTM)19.7×anip pe ratio ttm · anip price to earningsPE Ratio deep dive
Revenue (TTM)$923.7Manip revenue ttm · anip annual revenueFull revenue history
Dividend Yield不分红does anip pay dividends · anip dividend yieldDividend history
Shares Outstanding20.1Manip shares outstanding · anip floatShares outstanding history
Next EarningsAug 14, 2026Est.anip earnings date · anip next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$883.4M▲ +43.78% YoY
202320242025
ani pharmaceuticals, inc. revenue · anip revenue 2025
FY 2025Net Income$78.3M▲ +522.94% YoY
202320242025
ani pharmaceuticals, inc. net income · anip profit 2025
FY 2025EPS$3.50▲ +436.54% YoY
202320242025
anip eps · ani pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $923.7MNet Income: $89.7MEPS: $4.11View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy10 位分析师is anip a buy · anip analyst rating
Strong Buy
0
Buy
7
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$124.00Low
$81.11Current
$124.00Avg Target上涨空间 52.88%
$124.00High
anip price target · anip 12 month forecast

合计: 10 · 买入占比: 70.0%

根据过去 3 个月内 10 位华尔街分析师,ANIP 共识评级为 Buy,12 个月平均目标价 $124.00 (较现价 $81.11 上涨空间 52.88%)

股票表现

完整历史
1D+2.41%
1W+9.25%
1M-0.92%
3M+9.55%
YTD+2.75%
1Y+28.38%
5Y+131.15%

关于 ANI Pharmaceuticals, Inc.

CEONikhil Lalwani
IPO DateMay 5, 2000
Employees897
CountryUS

ANI Pharmaceuticals, Inc. a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing co…

what is ani pharmaceuticals, inc. · anip stock overview · ani pharmaceuticals, inc. company profile · who is ani pharmaceuticals, inc. ceo · anip NASDAQ · ani pharmaceuticals, inc. headquarters · ani pharmaceuticals, inc. business segments

关于股票概览与关键数据

ANI Pharmaceuticals, Inc.(ANIP)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 May 5, 2000 在 NASDAQ 上市。截至最近交易日,ANIP 股价为 $81.11,市值约为 $1.8B。过去12个月累计回报 +28.38%,年初至今回报 +2.75%。

根据 10 位华尔街分析师,ANI Pharmaceuticals, Inc. 股票共识评级为Buy,12个月平均目标价为 $124.00。2025 财年 ANI Pharmaceuticals, Inc. 营收 $883.4M,净利润 $78.3M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,ANI Pharmaceuticals, Inc.(ANIP)股价为 $81.11,在 NASDAQ 上市,52周区间为 $59.61 – $99.50。

ANIP 最新股价ANIP quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议